AdSana

AdSana

Created using Figma
Adsana has developed an effective and affordable Cancer Infusion Therapy that has shown to kill cancer cells and cancer stem cells in dogs and in humans. The Adsana Team intends to establish Treatment Centers to deliver a new low cost, highly effective treatment for cancer.
STO
1 sept. 2019
31 déc. 2019
100% terminé
Fonds levés - pas de données
past
PRE STO
1 juin 2019
1 sept. 2019
100% terminé
Fonds levés - pas de données
past
Détails supplémentaires
Les catégories
Plate-forme

Sur AdSana

THE ADSANA PROJECT

Adsana is launching our SECURITY TOKEN OFFERING and introducing our SANA security token.

This is an opportunity to be involved with an effective and affordable Cancer Infusion Therapy that kills cancer cells and cancer stem cells.

An opportunity to be involved in one of the highest growth industries world wide.  As stated in Science Daily “estimate a 1 percent reduction in mortality from cancer has a value to Americans of nearly $500 billion. A cure for cancer would be worth about $50 trillion.”  

This is not a concept.  This is a real treatment being used now.  Become part of the cancer revolution.

PAYMENT ASSURANCE PROGRAM

Through our Adsana App, a patient or dog owner will be able to pre-pay for the treatment in what we are calling Payment Assurance.  Once payment for services is made, it will be held securely within our decentralized blockchain/holochain platform.  Both the clinic and the patient or dog owner have Payment Assurance the treatment will be performed and the payment will be made.

NETWORK OF TREATMENT CLINICS

Our plan is to transition our Canine Infusion Therapy from a proven treatment for people to a repeatable proven treatment for canine cancer at our Canine Cancer Centers.  We will launch our Canine Cancer Centers first in the United States and then to Europe and Australia.

Projected treatment cost will be  18% to 25% less than typical chemotherapy drug treatments available now for treating cancer in dogs even though existing treatments have a poor prognosis after the treatment. 

ONGOING SCIENTIFIC RESEARCH

As part of Adsana’s continued clinical research, Adsana will store the treatment records for further clinical research. Additionally, Adsana will collect the DNA of the dogs treated.  

Also, as part of the clinic’s services, Adsana will offer DNA collection for all dogs.  Data collected will be stored within Adsana’s decentralized platform.   This data collected will have far-reaching results in treating, tracking and diagnosing of diseases in dogs, especially cancer.

AdSana Équipe

Vérifié 17%

Attention. Il y a un risque que les membres non vérifiés ne soient pas réellement membres de l'équipe

Gary D. Nice
Founder and Chief Executive Officer
vérifié
Russell J. Hall
Chief Operations Officer
non vérifié
Dr. Tom S. Tsang
Chief Science Officer
non vérifié
Dr. Amanda Beck
DVM, DACVIM (Oncology)
non vérifié
Gregory Kennedy
Chief Technical Project Manager
non vérifié
Prakash Patel
Graphic Designer
non vérifié

Conseillers

Vérifié 0%

Attention. Il y a un risque que les membres non vérifiés ne soient pas réellement membres de l'équipe

Justin Smith
Technical Holochain and AI Advisor
non vérifié
Colin Stewart
Technical Advisor
non vérifié
Uday Kumar Seethamse...
Technical Advisor and Blockchain Architect
non vérifié
Kiran Paturi
Technical Advisor
non vérifié
Lance Weisser
Technical Advisor
non vérifié

AdSana Entretiens

GARY D. NICE
As a team member, сan you tell us about your role in the ICO project?
I am the Founder and CEO of AdSana and very proud and excited to bring our treatment to the world. We have an effective, affordable Cancer Infusion Therapy that kills cancer cells in people and dogs. I have been working in cancer research since 2006 as the Founder and President of the National Canine Cancer Foundation.
What do you think about idea?
I am very excited and passionate about our treatment. How effective it is and how inexpensive it is. How can you not be excited when we kill cancer cells, so cancer is no longer a fatal disease.

AdSana Dernières nouvelles

OCT qui pourraient vous intéresser

  • En raison des différences temporelles dans les mises à jour des informations, des informations précises sur chaque projet ICO doivent être vérifiées sur son site web officiel ou via un autre canal de communication.
  • Cette information n'est pas une suggestion ou un conseil pour investir dans un financement ICO. Veuillez examiner vous-même les informations pertinentes et décider de la participation de l’OIC.
  • Si vous pensez que des problèmes ou des problèmes doivent être résolus concernant ce contenu, ou si vous souhaitez soumettre votre propre projet ICO pour figurer dans la liste, veuillez nous envoyer un courrier électronique.
Veuillez lire la clause de non-responsabilité et l'avertissement de risque. Afficher l'avertissement et l'avertissement de risque.